公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1996 | Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis | Hwang Y.-T.; PEI-JER CHEN ; JIA-HORNG KAO ; Wang T.-D.; Wang H.-H.; Chu J.-S.; Su I.-J.; DING-SHINN CHEN | Liver | 9 | 9 | |
2010 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO | Kidney International | 31 | 32 | |
2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
2019 | Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study | CHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 8 | |
2019 | Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C | SHIH-JER HSU ; Chiu M.-C.; YU-JEN FANG ; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN ; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 19 | 16 | |
2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
2020 | Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapy | Yang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; TUNG-HUNG SU ; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; JIA-HORNG KAO ; Yuen M.-F.; Yu M.-L.; Nguyen M.H. | Journal of Infectious Diseases | 58 | 49 | |
2020 | Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data | CHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 17 | 18 | |
2010 | Recent advances in clinical application of gut hormones | PING-HUEI TSENG ; MING-SHIANG WU ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 4 | 4 | |
2010 | Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Advances in Cancer Research | 72 | 68 | |
2011 | Recent advances in the treatment of chronic hepatitis B | Lin C.-L.; JIA-HORNG KAO | Expert Opinion on Pharmacotherapy | 26 | 26 | |
2002 | Recent research progress in hepatocellular carcinoma | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 20 | 21 | |
2002 | Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma | JIA-HORNG KAO ; DING-SHINN CHEN | International Journal of Cancer | 13 | 10 | |
2013 | Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy | Huang Y.-W.; Lin S.-C.; SHU-CHEN WEI ; Hu J.-T.; Chang H.-Y.; Huang S.-H.; DING-SHINN CHEN ; PEI-JER CHEN ; PING-NING HSU ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 44 | 37 | |
2014 | Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy | YI-WEN HUANG ; Hsu C.-K.; Lin S.-C.; SHU-CHEN WEI ; Hu J.-T.; Chang H.-Y.; Liang C.-W.; DING-SHINN CHEN ; PEI-JER CHEN ; PING-NING HSU ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 20 | 17 | |
2015 | Reimbursement policies in the Asia-Pacific for chronic hepatitis B | Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO ; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H. | Hepatology International | 21 | 19 | |
2001 | Relation of Chlamydia pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction or unstable angina pectoris | CHIA-TI TSAI ; JIA-HORNG KAO ; Hsu K.-L.; FU-TIEN CHIANG ; Tseng C.-D.; Liau C.-S.; Tseng Y.-Z.; HWANG, JUEY-JEN | American Journal of Cardiology | 4 | 4 | |
2020 | Relationship between serum gamma-glutamyl transferase level and colorectal adenoma | TZU-CHAN HONG ; HUNG-CHIH YANG ; CHI-LING CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU ; Chen M.-J; Wang H.-Y; Kuo Y.-C; Yu L.-Y; Hu K.-C. | PLoS ONE | 4 | 2 | |
2024 | Reply | SHANG-CHIN HUANG ; TUNG-HUNG SU ; JIA-HORNG KAO | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |